Because inflammatory bacterial LPS induces microglial activation via the toll-like receptor (TLR)-4 pathway to cause neurological diseases [48], the effect of inhibiting LPS-induced microglial inflammatory responses is widely used to screen active substances for neurodegenerative diseases. This evidence concerns the gene TLR4 and nervous system disorder.